"Government Regulation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Exercise of governmental authority to control conduct.
| Descriptor ID |
D033161
|
| MeSH Number(s) |
I01.880.604.394 N03.706.358
|
| Concept/Terms |
Government Regulation- Government Regulation
- Government Regulations
- Regulation, Government
- Regulations, Government
|
Below are MeSH descriptors whose meaning is more general than "Government Regulation".
Below are MeSH descriptors whose meaning is more specific than "Government Regulation".
This graph shows the total number of publications written about "Government Regulation" by people in this website by year, and whether "Government Regulation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 0 | 1 | 1 |
| 1996 | 1 | 0 | 1 |
| 1997 | 2 | 1 | 3 |
| 1998 | 1 | 0 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 1 | 1 | 2 |
| 2003 | 1 | 1 | 2 |
| 2004 | 2 | 0 | 2 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 2 | 1 | 3 |
| 2008 | 0 | 1 | 1 |
| 2009 | 2 | 3 | 5 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 2 | 2 |
| 2017 | 2 | 0 | 2 |
| 2018 | 0 | 3 | 3 |
| 2019 | 3 | 1 | 4 |
| 2020 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Government Regulation" by people in Profiles.
-
Molecular Pathology Economics 101: An Overview of Molecular Diagnostics Coding, Coverage, and Reimbursement: A Report of the Association for Molecular Pathology. J Mol Diagn. 2020 08; 22(8):975-993.
-
Public reporting of hydraulic fracturing chemicals in the USA, 2011-18: a before and after comparison of reporting formats. Lancet Planet Health. 2020 05; 4(5):e178-e185.
-
Flavored E-cigarette Use and Progression of Vaping in Adolescents. Pediatrics. 2019 11; 144(5).
-
Opaque Results of Federal Price Transparency Rules and State-Based Alternatives. J Oncol Pract. 2019 09; 15(9):463-464.
-
US State Regulation of Decisions for Pregnant Women Without Decisional Capacity. JAMA. 2019 04 23; 321(16):1629-1631.
-
The Role of Cannabis in the Management of Inflammatory Bowel Disease: A Review of Clinical, Scientific, and Regulatory Information. Inflamm Bowel Dis. 2019 02 21; 25(3):427-435.
-
A Retrospective Estimate of Ear Disease Detection Using the "Red Flags" in a Clinical Sample. Ear Hear. 2018 Sep-Oct; 39(5):1035-1038.
-
Sucroferric oxyhydroxide for the treatment of hyperphosphatemia. Expert Opin Pharmacother. 2018 Jul; 19(10):1137-1148.
-
Rationale, Opportunities, and Reality of Biosimilar Medications. N Engl J Med. 2018 May 24; 378(21):2036-2044.
-
Due to potential concerns of bias and conflicts of interest, regulatory bodies should not do evaluation methodology research related to their regulatory missions. Med Phys. 2017 09; 44(9):4403-4406.